当前位置:首页 - 行情中心 - 国际医学(000516) - 财务分析

国际医学

(000516)

  

流通市值:105.61亿  总市值:107.24亿
流通股本:22.05亿   总股本:22.39亿

国际医学(000516)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-3.74亿元,每股收益-0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益305427.03万元,未分配利润-27368.50万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产979065.65万元,负债673638.62万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,995,437,323.472,034,307,690.46997,091,245.374,815,466,752.34
营业总成本3,379,382,067.182,279,057,237.691,144,868,275.735,180,946,550.96
其他经营收益
营业利润-360,502,200.22-211,663,325.64-128,892,235.38-342,182,324
利润总额-360,210,877.21-213,131,740.97-130,667,276.25-344,644,061.86
净利润-374,029,115.97-218,312,970.23-132,959,986.79-365,139,719.05
每股收益
其他综合收益----
综合收益总额-374,029,115.97-218,312,970.23-132,959,986.79-365,139,719.05
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,150,867,696.81,185,953,128.621,357,462,403.541,615,075,051.84
非流动资产:
非流动资产合计8,639,788,816.098,819,558,543.58,961,380,479.319,021,246,941.05
资产总计9,790,656,512.8910,005,511,672.1210,318,842,882.8510,636,321,992.89
流动负债:
流动负债合计4,229,596,306.024,210,763,756.214,075,263,256.044,151,485,482.84
非流动负债:
非流动负债合计2,506,789,865.022,584,771,936.462,904,549,572.583,012,846,469.03
负债合计6,736,386,171.046,795,535,692.676,979,812,828.627,164,331,951.87
所有者权益(或股东权益):
归属于母公司股东权益合计3,337,580,628.583,466,264,833.363,568,573,896.313,674,927,755.19
股东权益合计3,054,270,341.853,209,975,979.453,339,030,054.233,471,990,041.02
负债和股东权益合计9,790,656,512.8910,005,511,672.1210,318,842,882.8510,636,321,992.89
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,200,253,779.932,235,548,073.731,076,605,731.634,839,806,934.78
经营活动现金流出小计2,279,249,924.381,643,006,109.68832,801,572.273,830,687,121.57
经营活动产生的现金流量净额921,003,855.55592,541,964.05243,804,159.361,009,119,813.21
投资活动产生的现金流量:
投资活动现金流入小计88,216,010.8988,210,678.8978,194,869.3952,552,409.03
投资活动现金流出小计235,376,144.3207,482,673.01149,882,648.02558,740,389.83
投资活动产生的现金流量净额-147,160,133.41-119,271,994.12-71,687,778.63-506,187,980.8
筹资活动产生的现金流量:
筹资活动现金流入小计266,310,000203,010,00099,980,000717,480,000
筹资活动现金流出小计1,345,642,955.84959,029,573.49451,055,002.21,615,812,467.85
筹资活动产生的现金流量净额-1,079,332,955.84-756,019,573.49-351,075,002.2-898,332,467.85
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-305,489,233.7-282,749,603.56-178,958,621.47-395,400,635.44
期末现金及现金等价物余额243,072,769.68265,812,399.82369,603,381.91548,562,003.38
补充资料:
现金及现金等价物的净增加额--282,749,603.56--395,400,635.44
最新报告期:2025-08-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
东海证券杜永宏-0.06-0.040.012025-08-26
TOP↑